On March 17, 2025, Breeze Holdings Acquisition Corp. was notified that it is not compliant with OTCQX listing requirements, needing to meet specific financial criteria by June 13, 2025, to avoid delisting. The company is pursuing a business combination with YD Biopharma Limited, which must be listed on NASDAQ upon closing.